Clinical Trials in Houston

Showing 3441-3460 of 15,366 trials

A Neurosensory Account of Anxiety and Stress (Study 1)

NCT05895006

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Posttraumatic Stress Disorder (PTSD)Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition

The University of Texas Health Science Center, Houston160 participantsStarted Apr 2022

Houston, Texas, United States

Active Not RecruitingPhase 3< 1 mile

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

NCT05270837

This is a Phase 3 open-label randomized controlled study enrolling approximately 54 adolescents with PKU. The study is designed to assess the safety and efficacy of pegvaliase injections.

Phenylketonuria (PKU)

BioMarin Pharmaceutical55 participantsStarted Jun 2022

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Aurora, Colorado, United States +13 more locations

A Neurosensory Account of Anxiety and Stress (Study 1)

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

Find Trials by Condition in Houston

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders